Altshuler Shaham’s Tandem Diabetes Care TNDM Stock Holding History

Altshuler Shaham’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-365	Closed	-$42K	–	557
2022 Q1	$42K	Sell	365 -473	-56%	-$55.2K	﹤0.01%	392
2021 Q4	$126K	Buy	838 +399	+91%	+$53.9K	﹤0.01%	312
2021 Q3	$53K	Buy	+439	New	+$48.4K	﹤0.01%	403
2020 Q4	–	Sell	-664	Closed	-$75K	–	465
2020 Q3	$75K	Buy	664 +29	+5%	+$3.05K	﹤0.01%	201
2020 Q2	$63K	Buy	+635	New	+$50.7K	﹤0.01%	183
2019 Q3	–	Sell	-143	Closed	-$9K	–	551
2019 Q2	$9K	Buy	+143	New	+$9.23K	﹤0.01%	310

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Altshuler Shaham's TNDM Position: Q2 2022 in Review

Altshuler Shaham sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 365 shares — an estimated $42K sold.

Altshuler Shaham first reported a position in TNDM in Q2 2019 and held it in 6 quarters. The position peaked at $126K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

Altshuler Shaham reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
Altshuler Shaham sold 365 Tandem Diabetes Care shares in Q2 2022, an estimated $42K.
Altshuler Shaham first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 6 quarters.
Altshuler Shaham's Tandem Diabetes Care position peaked at $126K in Q4 2021.
330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Altshuler Shaham's 13F filing for Q2 2022, filed 10 Aug 2022.